Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yu.E. Balykina"'
Publikováno v:
Педиатрическая фармакология, Vol 7, Iss 5, Pp 12-16 (2010)
Since the time antibacterial agents were introduced into a wider medical practice, they have dramatically changed illness patterns and significantly reduced the metrics such as attributive mortality from infectious diseases. At the same time, in rece
Externí odkaz:
https://doaj.org/article/93d187b232d8413883574813071ee7e2
Publikováno v:
Pharmacoeconomics: theory and practice. 10:17-21
Diabetic retinopathy (DR) is a specific neuromicrovascular complication of diabetes mellitus. Diabetic macular edema (DME) is a retinal thickening associated with fluid accumulation in the intercellular space of the neuroep- ithelium due to hematoret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bad6a7cb292ed405cc2cbbb32e504185
https://doi.org/10.30809/phe.4.2022.3
https://doi.org/10.30809/phe.4.2022.3
Publikováno v:
Clinical oncohematology. 15:85-96
Background. The implementation of new FLT3-targeted drugs in clinical practice has changed the approaches to the management of patients with acute myeloid leukemias (AML) with FLT3 mutation. One of these drugs is gilteritinib, approved by FDA in 2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fcb0d35d10ae5e72f5a0b53de78eba6
https://doi.org/10.21320/2500-2139-2022-15-1-85-96
https://doi.org/10.21320/2500-2139-2022-15-1-85-96
Publikováno v:
Clinical Microbiology and Antimicrobial Chemotherapy. 24:93-107
Objective. To evaluate safety of anti-interleukin drugs used as a pathogenetic therapy of COVID-19 as assessed by risks of infectious complications. Materials and Methods. A systematic review of publications related to safety assessment of anti-inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d81be9951c9bd4721ba6367fa2b985
https://doi.org/10.36488/cmac.2022.2.93-107
https://doi.org/10.36488/cmac.2022.2.93-107
Publikováno v:
Pharmacoeconomics: theory and practice. 8:17-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::080d02f1775ae4172a42f8a33706baa0
https://doi.org/10.30809/phe.4.2020.3
https://doi.org/10.30809/phe.4.2020.3
Publikováno v:
Современная онкология, Vol 19, Iss 1, Pp 48-53 (2017)
This article represents data on economic evaluation of treatment with ixabepilone (Ixempra) as a single agent for patients with metastatic breast cancer with ineffective pretreatment with taxanes, anthracyclines and capecitabine. Two health technolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c07efb22d7f8e4343c15860b0f1dddc9
https://modernonco.orscience.ru/1815-1434/article/viewFile/27120/pdf
https://modernonco.orscience.ru/1815-1434/article/viewFile/27120/pdf
Publikováno v:
Russian Journal of Allergy. 12:49-58
For the first time in Russian economic conditions clinical and economic evaluation of the appropriateness of tiotropium bromide as adjunctive therapy (in addition to the standard therapy) was carried out in patients with severe asthma. Markov model w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62c8025c2895da80f0a4eb5f53411b18
https://doi.org/10.36691/rja439
https://doi.org/10.36691/rja439
Publikováno v:
Pharmacoeconomics: theory and practice. 3:22-27
2i/v every 3 weeks. Mathematical modelling underlies this study. As a result it has been demonstrated that the use of vemurafenib strategy in treatment of metastatic melanoma in patients with BRAF V600 mutation had better progression-free survival (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e1e5303fb7e06df7e8b1e186c2bc94d
https://doi.org/10.30809/phe.4.2015.4
https://doi.org/10.30809/phe.4.2015.4
Publikováno v:
Фармакоэкономика, Vol 8, Iss 1, Pp 39-46 (2015)
We have performed the first-ever Budget Impact Analysis (BIA) in a Russian context of bendamustine in the first line of therapy of a multiple myeloma for patients more senior 65 years old with clinical manifestations of a polineuropathy, which autolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4a9b6eaab5fe05cb9edc572638dc31
https://www.pharmacoeconomics.ru/jour/article/view/96
https://www.pharmacoeconomics.ru/jour/article/view/96
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.